Ahead of her presentation at JP Morgan, Pharmaceutical Technology spoke with Dr. Jennifer Levin Carter, MD, founder and CEO ...

In October 2025, Sharp announced plans to invest $100 million across its United States and European facilities to expand ...

Oral semaglutide was approved by the FDA in December 2025 as a once-daily pill (25 mg), intended to limit excess body weight ...

In Episode 227 of The Robot Report Podcast, hosts Steve Crowe and Mike Oitzman recap the major robotics news of the week.

Strive Compounding Pharmacy alleges the two pharma companies are coordinating an effort to restrict compounded access.

The arrival of oral Wegovy across 70,000 US pharmacies offers a more affordable and convenient weight-loss treatment option ...